Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Investigational New Drugs|June 24, 2022
Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancerHisao Imai, Yoshiaki Nagai, Hiroyuki Minemura, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2023
Subsequent treatment for locally advanced non-small-cell lung cancer that progressed after definitive chemoradiotherapy and consolidation therapy with durvalumab: a multicenter retrospective analysis (TOPGAN 2021-02)Tsukasa Hasegawa, Ryo Ariyasu, Hisashi Tanaka, et al.
European Journal of Cancer (Oxford, England : 1990)|December 7, 2023
A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study)Satoshi Watanabe, Naoki Furuya, Atsushi Nakamura, et al.
Thoracic Cancer|September 5, 2022
Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survivalKen Masubuchi, Hisao Imai, Satoshi Wasamoto, et al.
Frontiers in Oncology|February 6, 2023
Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancerSatoshi Wasamoto, Hisao Imai, Takeshi Tsuda, et al.
JAMA Oncology|March 7, 2024
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung CancerYoko Tsukita, Takehiro Tozuka, Kohei Kushiro, et al.
Pageof 3